In one study, a significant overexpression of Ku80 was observed in primary human lung adenocarcinoma, which was associated with poor clinical outcomes and resistance to cisplatin-based chemotherapy [8]. This evidence concerns the gene XRCC5 and lung adenocarcinoma.